- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00633607
Hereditary Colorectal and Associated Tumor Registry Study
February 15, 2018 updated by: Randall Brand, University of Pittsburgh
After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample.
Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories.
Data and biospecimens will be stored for potential future research projects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
114
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15232
- University of Pittsburgh
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 100 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Potential research subjects are recruited from our Hereditary GI clinic.
Description
Inclusion Criteria:
- Identified gene mutation
- Personal history of colorectal cancer diagnosed ≤ 50
- Personal history of cancer with tumor studies suggestive of Lynch syndrome
- Personal history of multiple primary tumors associated with a hereditary cancer syndrome (colorectal, uterus, stomach, ovary, small bowel, hepatobiliary tract, transitional cell carcinoma of the renal pelvis/ureter, brain)
- Personal history of one of the above cancers and a family history of one or more of the above cancers
- Personal or family history of diffuse gastric cancer
- From a known genetic predisposition family
- Personal history of > 10 colon adenomas (cumulative over a lifetime)
- Personal history of any number of hamartomatous polyps
- Personal history of multiple large (> 1cm) serrated polyps to right of sigmoid
Exclusion critera:
- Individuals under the age of 8
- Individuals who cannot travel to Pittsburgh for in-person enrollment
- Individuals who cannot provide informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Establish a Hereditary Colorectal Tumor Registry to facilitate development and implementation of epidemiological, clinical and cancer control research.
Time Frame: 1-N/A (up to 8 years)
|
1-N/A (up to 8 years)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (ACTUAL)
January 26, 2018
Study Completion (ACTUAL)
January 26, 2018
Study Registration Dates
First Submitted
March 3, 2008
First Submitted That Met QC Criteria
March 11, 2008
First Posted (ESTIMATE)
March 12, 2008
Study Record Updates
Last Update Posted (ACTUAL)
February 19, 2018
Last Update Submitted That Met QC Criteria
February 15, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Metabolic Diseases
- Skin Diseases
- Neoplasms
- Neoplasms by Site
- Disease
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Genetic Diseases, Inborn
- Colonic Diseases
- Intestinal Diseases
- Intestinal Neoplasms
- Colorectal Neoplasms
- Neoplastic Syndromes, Hereditary
- DNA Repair-Deficiency Disorders
- Intestinal Polyposis
- Hyperpigmentation
- Pigmentation Disorders
- Melanosis
- Lentigo
- Syndrome
- Colorectal Neoplasms, Hereditary Nonpolyposis
- Peutz-Jeghers Syndrome
Other Study ID Numbers
- 04-112
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lynch Syndrome
-
San Raffaele UniversityRecruitingColorectal Cancer | Lynch Syndrome | Colo-rectal Cancer | Colon Adenoma | Colon Disease | MLH1 Gene Mutation | Adenoma Colon | Colon Neoplasm | Mismatch Repair Deficiency | Lynch Syndrome I (Site-specific Colonic Cancer) | MSH2 Gene Mutation | MSH6 Gene Mutation | PMS2 Gene Mutation | EPCAM Gene Mutation | Lynch Syndrome... and other conditionsItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHigh-Frequency Microsatellite Instability | Mismatch Repair Gene Mutation | Mutation-Negative Lynch Syndrome | Mutation-Positive Lynch SyndromeUnited States
-
San Raffaele UniversityHumanitas Hospital, Italy; Unita' di Gastroenterologia - Policlinico Universitario... and other collaboratorsRecruitingLynch Syndrome | MLH1 Gene Mutation | MSH2 Gene Mutation | MSH6 Gene Mutation | PMS2 Gene Mutation | Lynch Syndrome II | Small Bowel Adenocarcinoma | Lynch Syndrome IItaly
-
San Raffaele UniversityRecruitingLynch Syndrome | HNPCC | MLH1 Gene Mutation | Hereditary Cancer | Lynch Syndrome I (Site-specific Colonic Cancer) | MSH2 Gene Mutation | MSH6 Gene Mutation | PMS2 Gene Mutation | Lynch Syndrome II | Hereditary Cancer Syndrome | Lynch Syndrome I | HNPCC Gene Mutation | MLH1 Gene Deletion+Duplication | MLH1 Loss of... and other conditionsUnited States, Italy
-
Tel-Aviv Sourasky Medical CenterRambam Health Care Campus; Rabin Medical Center; Sheba Medical Center; Soroka University...Not yet recruitingLynch Syndrome I (Site-specific Colonic Cancer)Israel
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingLynch Syndrome | Epidermoid Carcinoma | Muir-Torre Syndrome | Basal Cell Carcinoma of Skin, Site Unspecified
-
UNICANCERNot yet recruitingLynch SyndromeNorway, Latvia, United Kingdom, Netherlands, Czechia, Croatia, Finland, France, Italy
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)Not yet recruitingLynch Syndrome | Hereditary Neoplastic Syndrome | BRCA1-Related Hereditary Breast and Ovarian Cancer Syndrome | BRCA2-Related Hereditary Breast and Ovarian Cancer SyndromeUnited States
-
University of Colorado, DenverJohns Hopkins University; University of Manitoba; University of Pennsylvania; University... and other collaboratorsRecruiting
-
University of Vermont Medical CenterEnrolling by invitationLynch Syndrome | Hereditary Cancer Syndromes | BRCA1 Hereditary Breast and Ovarian Cancer SyndromeUnited States
Clinical Trials on Research Registry
-
University of PittsburghCompleted
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)CompletedCognitive Dysfunction | Dementia | Alzheimer Disease | Lewy Body Disease | Frontotemporal DementiaUnited States
-
Queen Mary University of LondonRecruitingInfective Endocarditis | Endocarditis, Bacterial | EndocarditisUnited Kingdom
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...RecruitingAchondroplasia | HypochondroplasiaItaly
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Recruiting
-
University of UlmRecruiting
-
Swiss Hemophilia NetworkRecruiting
-
University of California, San FranciscoAgency for Healthcare Research and Quality (AHRQ)TerminatedProstatic NeoplasmsUnited States
-
University of California, San FranciscoAgency for Healthcare Research and Quality (AHRQ)CompletedHead and Neck NeoplasmsUnited States
-
Fundació Institut Germans Trias i PujolGermans Trias i Pujol Hospital; Hospital Donostia; Hospital de Basurto; Hospital... and other collaboratorsRecruitingMyotonic Dystrophy Type 1 | Myotonic Dystrophy 1 | DM1 | Steinert Disease | Myotonic Dystrophy, CongenitalSpain